These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 15827407)
1. FDG uptake in a catheter-related thrombus simulating relapse of lymphoma. Siösteen AK; Celsing F; Jacobsson H Clin Nucl Med; 2005 May; 30(5):338-9. PubMed ID: 15827407 [TBL] [Abstract][Full Text] [Related]
2. FDG uptake in tumor thrombus in inferior vena cava from rectal cancer on positron emission tomography. Gupta P; Kramer EL; Ponzo F Clin Nucl Med; 2005 May; 30(5):342-3. PubMed ID: 15827409 [TBL] [Abstract][Full Text] [Related]
3. Catheter-related focal FDG activity on whole body PET imaging. Bhargava P; Kumar R; Zhuang H; Charron M; Alavi A Clin Nucl Med; 2004 Apr; 29(4):238-42. PubMed ID: 15096970 [TBL] [Abstract][Full Text] [Related]
4. PET/computed tomography and lymphoma. Allen-Auerbach M; de Vos S; Czernin J Radiol Clin North Am; 2013 Sep; 51(5):833-44. PubMed ID: 24010908 [TBL] [Abstract][Full Text] [Related]
5. Recurrence of lymphoma presenting as asymmetrically increased testicular activity on FDG-PET/CT. Kuo PH; Cooper DL; Cheng DW Semin Nucl Med; 2006 Jan; 36(1):105-7. PubMed ID: 16356799 [No Abstract] [Full Text] [Related]
6. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma. Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328 [TBL] [Abstract][Full Text] [Related]
7. The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients. Allen-Auerbach M; de Vos S; Czernin J Radiol Clin North Am; 2008 Mar; 46(2):199-211, vii. PubMed ID: 18619376 [TBL] [Abstract][Full Text] [Related]
8. 18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence. Isohashi K; Tatsumi M; Higuchi I; Inoue A; Nakajo K; Ishikawa J; Shimosegawa E; Kanakura Y; Nakamura H; Hatazawa J Ann Nucl Med; 2008 Nov; 22(9):795-802. PubMed ID: 19039558 [TBL] [Abstract][Full Text] [Related]
10. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. Bar-Shalom R; Gaitini D; Keidar Z; Israel O Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1105-13. PubMed ID: 15007566 [TBL] [Abstract][Full Text] [Related]
11. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility. Basu S; Li G; Bural G; Alavi A Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692 [TBL] [Abstract][Full Text] [Related]
12. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma. Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697 [TBL] [Abstract][Full Text] [Related]
13. (18)F-FDG PET/CT for discrimination between tumor extension and blood thrombus in pancreatic adenocarcinoma associated with portal vein thrombosis. Roldán-Valadez E; Ortega-López N; Valdivieso-Cárdenas G; Vega-González I; Herrera-Gómez A Rev Esp Med Nucl; 2008; 27(1):40-4. PubMed ID: 18208781 [TBL] [Abstract][Full Text] [Related]
14. [Acute deep venous thrombosis and PET scanning with 2-fluoro-2-deoxy-D-glucose, FDG]. Jensen RB; Mortensen J; Dreyer M Ugeskr Laeger; 2001 Sep; 163(38):5209-11. PubMed ID: 11577529 [TBL] [Abstract][Full Text] [Related]
15. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial. Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593 [TBL] [Abstract][Full Text] [Related]
16. (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. Weiler-Sagie M; Bushelev O; Epelbaum R; Dann EJ; Haim N; Avivi I; Ben-Barak A; Ben-Arie Y; Bar-Shalom R; Israel O J Nucl Med; 2010 Jan; 51(1):25-30. PubMed ID: 20009002 [TBL] [Abstract][Full Text] [Related]
17. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET. Yun M; Choi HS; Yoo E; Bong JK; Ryu YH; Lee JD J Nucl Med; 2005 Jun; 46(6):953-7. PubMed ID: 15937305 [TBL] [Abstract][Full Text] [Related]
18. Case report: internal and external jugular vein thrombosis with marked accumulation of FDG. Kikuchi M; Yamamoto E; Shiomi Y; Nakamoto Y; Shiomi Y; Fujiwara K; Watanabe F; Shinohara S Br J Radiol; 2004 Oct; 77(922):888-90. PubMed ID: 15483006 [TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma tumour thrombus in a re-canalised para-umbilical vein: detection by 18-fluoro-2-deoxyglucose positron emission tomography imaging. Beadsmoore CJ; Cheow HK; Sala E; Lomas DJ; Gibbs P; Save V; Alison ME; Balan KK Br J Radiol; 2005 Sep; 78(933):841-4. PubMed ID: 16110108 [TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET in malignant lymphoma: significance of positive findings. Castellucci P; Zinzani P; Pourdehnad M; Alinari L; Nanni C; Farsad M; Battista G; Tani M; Stefoni V; Canini R; Monetti N; Rubello D; Alavi A; Franchi R; Fanti S Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):749-56. PubMed ID: 15785956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]